Viewing StudyNCT00242320



Ignite Creation Date: 2024-05-05 @ 12:07 PM
Last Modification Date: 2024-10-26 @ 9:20 AM
Study NCT ID: NCT00242320
Status: COMPLETED
Last Update Posted: 2016-12-02
First Post: 2005-10-19

Brief Title: Efficacy and Safety of Oral Roflumilast Taken Once Daily in Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease BY217M2-119
Sponsor: AstraZeneca
Organization: AstraZeneca

Conditions & Keywords Data

Conditions:
Name
COPD
Keywords:
Name View
Roflumilast View
COPD View
chronic obstructive pulmonary disease View